Mouse Anti-PRNP Recombinant Antibody (8H4) (CBMAB-0715CQ)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu2+ or Zn2+ for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity).
Calcium-mediated signaling using intracellular calcium sourceManual Assertion Based On ExperimentIGI:ARUK-UCL
Cell cycleIEA:UniProtKB-KW
Cellular copper ion homeostasis1 PublicationNAS:UniProtKB
Cellular response to amyloid-betaManual Assertion Based On ExperimentIGI:ARUK-UCL
Cellular response to copper ionManual Assertion Based On ExperimentIDA:MGI
Cellular response to xenobiotic stimulusIEA:Ensembl
Dendritic spine maintenanceManual Assertion Based On ExperimentTAS:ARUK-UCL
Learning or memoryISS:ARUK-UCL
Long-term memoryManual Assertion Based On ExperimentTAS:ARUK-UCL
Negative regulation of activated T cell proliferationISS:BHF-UCL
Negative regulation of amyloid precursor protein catabolic processISS:ARUK-UCL
Negative regulation of amyloid-beta formationISS:ARUK-UCL
Negative regulation of apoptotic processIEA:Ensembl
Negative regulation of calcineurin-NFAT signaling cascadeISS:BHF-UCL
Negative regulation of dendritic spine maintenanceISS:ARUK-UCL
Negative regulation of DNA-binding transcription factor activityISS:BHF-UCL
Negative regulation of interferon-gamma productionISS:BHF-UCL
Negative regulation of interleukin-17 productionISS:BHF-UCL
Negative regulation of interleukin-2 productionISS:BHF-UCL
Negative regulation of long-term synaptic potentiationIEA:Ensembl
Negative regulation of protein phosphorylationISS:BHF-UCL
Negative regulation of protein processingManual Assertion Based On ExperimentTAS:ARUK-UCL
Negative regulation of T cell receptor signaling pathwayISS:BHF-UCL
Neuron projection maintenanceISS:ARUK-UCL
Positive regulation of neuron apoptotic processManual Assertion Based On ExperimentIMP:CAFA
Positive regulation of neuron deathISS:ARUK-UCL
Positive regulation of peptidyl-tyrosine phosphorylationManual Assertion Based On ExperimentIDA:ARUK-UCL
Positive regulation of protein localization to plasma membraneIEA:Ensembl
Positive regulation of protein targeting to membraneISS:ARUK-UCL
Positive regulation of protein tyrosine kinase activityManual Assertion Based On ExperimentIGI:ARUK-UCL
Protein destabilizationManual Assertion Based On ExperimentIMP:CAFA
Protein homooligomerizationIEA:InterPro
Regulation of calcium ion import across plasma membraneISS:ARUK-UCL
Biological Process regulation of glutamate receptor signaling pathwayISS:ARUK-UCL
Biological Process regulation of intracellular calcium activated chloride channel activityManual Assertion Based On ExperimentIGI:ARUK-UCL
Regulation of peptidyl-tyrosine phosphorylationISS:ARUK-UCL
Regulation of potassium ion transmembrane transportIEA:Ensembl
Response to amyloid-betaISS:ARUK-UCL
Response to cadmium ionIEA:Ensembl
Response to oxidative stressISS:UniProtKB
Golgi apparatus
Targeted to lipid rafts via association with the heparan sulfate chains of GPC1. Colocates, in the presence of Cu2+, to vesicles in para- and perinuclear regions, where both proteins undergo internalization. Heparin displaces PRNP from lipid rafts and promotes endocytosis.
Occurs primarily as a sporadic disorder (1 per million), while 10-15% are familial. Accidental transmission of CJD to humans appears to be iatrogenic (contaminated human growth hormone (HGH), corneal transplantation, electroencephalographic electrode implantation, etc.). Epidemiologic studies have failed to implicate the ingestion of infected animal meat in the pathogenesis of CJD in human. The triad of microscopic features that characterize the prion diseases consists of (1) spongiform degeneration of neurons, (2) severe astrocytic gliosis that often appears to be out of proportion to the degree of nerve cell loss, and (3) amyloid plaque formation. CJD is characterized by progressive dementia and myoclonic seizures, affecting adults in mid-life. Some patients present sleep disorders, abnormalities of high cortical function, cerebellar and corticospinal disturbances. The disease ends in death after a 3-12 months illness.
Fatal familial insomnia (FFI):
Autosomal dominant disorder and is characterized by neuronal degeneration limited to selected thalamic nuclei and progressive insomnia.
Gerstmann-Straussler disease (GSD):
A rare inherited prion disease characterized by adult onset of memory loss, dementia, ataxia, and pathologic deposition of amyloid-like plaques in the brain. GSD presents with progressive limb and truncal ataxia, dysarthria, and cognitive decline in the thirties and forties, and the average disease duration is 7 years.
Huntington disease-like 1 (HDL1):
Autosomal dominant, early-onset neurodegenerative disorder with prominent psychiatric features.
Kuru (KURU):
Kuru is transmitted during ritualistic cannibalism, among natives of the New Guinea highlands. Patients exhibit various movement disorders like cerebellar abnormalities, rigidity of the limbs, and clonus. Emotional lability is present, and dementia is conspicuously absent. Death usually occurs from 3 to 12 month after onset.
Spongiform encephalopathy with neuropsychiatric features (SENF):
Autosomal dominant presenile dementia with a rapidly progressive and protracted clinical course. The dementia was characterized clinically by frontotemporal features, including early personality changes. Some patients had memory loss, several showed aggressiveness, hyperorality and verbal stereotypy, others had parkinsonian symptoms.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Mouse Anti-PRNP Recombinant Antibody (3F4) (CAT#: CBMAB-C1121-LY)
Mouse Anti-PRNP Recombinant Antibody (CBT3573) (CAT#: V2LY-0625-LY1238)
Mouse Anti-PRNP Recombinant Antibody (5121) (CAT#: CBMAB-C7145-LY)
Mouse Anti-PRNP Recombinant Antibody (ROS-BC6) (CAT#: CBMAB-C12225-LY)
Rabbit Anti-PRNP Recombinant Antibody (BA0031) (CAT#: CBMAB-0707CQ)
Human Anti-PRNP Recombinant Antibody (CBXC-0741) (CAT#: CBMAB-C1855-CQ)
Mouse Anti-PRNP Recombinant Antibody (5B9) (CAT#: CBMAB-0716CQ)
Rabbit Anti-PRNP Recombinant Antibody (V21-V) (CAT#: CBMAB-0711CQ)
Mouse Anti-PRNP Recombinant Antibody (F89/160.1.5) (CAT#: CBMAB-0720CQ)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
